Cyclacel Pharmaceuticals (CYCC) Stock Chart & Stock Price History $1.57 -0.18 (-10.29%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$1.60 +0.02 (+1.59%) As of 09:15 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cyclacel Pharmaceuticals Stock Price Performance The Cyclacel Pharmaceuticals (CYCC) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 95.50%, with a year-to-date return of -73.90%. In the past month, the stock has decreased 56.50%, reflecting recent market activity. As of the latest close, Cyclacel Pharmaceuticals traded at $1.57 with a market cap of $20.35 million and volume of 278,830 shares. Five years ago, the stock traded at a split-adjusted price of $1,286.40, representing a 99.88% decrease over that period. At the time, it had a market cap of $3.95 million and a volume of 7,869 shares. Receive CYCC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cyclacel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-21.50%1 Month Performance-56.50%3 Month Performance-71.14%Year-To-Date Performance-73.90%1 Year Performance-95.50%5 Year Performance-99.88% CYCC Stock Chart for Thursday, May, 22, 2025 CYCC Chart by TradingView Cyclacel Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/21/2025$1.75$1.57-10.29%$1.87$1.53278,830 shs$20.35 million05/20/2025$2.00$1.75-12.50%$2.15$1.67237,019 shs$22.68 million05/19/2025$2.00$2.00$2.05$1.90157,755 shs$25.92 million05/16/2025$2.20$2.00-9.09%$2.31$1.95144,475 shs$414.67 million05/15/2025$2.32$2.20-5.17%$2.50$2.15180,474 shs$456.14 million05/14/2025$2.75$2.32-15.64%$2.77$2.21252,119 shs$481.02 million05/13/2025$3.59$2.75-23.40%$3.93$2.69325,659 shs$570.17 million05/12/2025$0.25$3.59+1,312.83%$4.61$3.52160,429 shs$744.34 million05/09/2025$4.86$4.07-16.41%$5.21$4.0078,535 shs$52.68 million05/08/2025$5.09$4.86-4.40%$5.55$4.7760,221 shs$63.03 million Get the Latest News and Ratings for CYCC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cyclacel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/07/2025$5.66$5.09-10.17%$5.52$4.55118,749 shs$65.93 million05/06/2025$4.78$5.66+18.43%$5.85$4.82187,195 shs$61.97 million05/05/2025$4.02$4.78+18.99%$5.25$4.01262,498 shs$61.97 million05/02/2025$3.91$4.02+2.74%$4.22$3.60102,882 shs$52.08 million05/01/2025$4.13$3.91-5.31%$4.72$3.84130,722 shs$50.69 million04/30/2025$4.86$4.13-15.01%$4.42$3.79294,286 shs$53.53 million04/29/2025$4.56$4.86+6.48%$6.56$3.656.82 million shs$62.99 million04/28/2025$4.46$4.56+2.44%$6.72$4.00684,898 shs$59.15 million04/25/2025$3.66$4.46+21.62%$4.80$3.62232,697 shs$57.74 million04/24/2025$3.68$3.66-0.52%$3.83$3.4723,307 shs$47.48 million04/23/2025$3.61$3.68+2.04%$3.76$3.5234,961 shs$47.73 million04/22/2025$3.38$3.61+6.87%$3.68$3.383,880 shs$46.78 million04/21/2025$3.62$3.38-6.63%$3.74$3.377,341 shs$43.77 million Related Companies Merus Stock Chart ACADIA Pharmaceuticals Stock Chart Catalyst Pharmaceuticals Stock Chart MorphoSys Stock Chart Protagonist Therapeutics Stock Chart Metsera Stock Chart Xenon Pharmaceuticals Stock Chart MoonLake Immunotherapeutics Stock Chart Immunovant Stock Chart HUTCHMED Stock Chart Receive CYCC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cyclacel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CYCC) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredExclusive Offer: Target 100% Returns NowBrace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...ProsperityPub | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclacel Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyclacel Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CYCC Stock Free CYCC Stock Alerts